注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
ADMA Biologics Inc是一家生物制药公司。该公司开发、制造和销售用于治疗和预防传染病的专业血浆生物制剂。该公司从事人血浆和血浆衍生疗法的开发和销售业务。其患者包括免疫功能低下的个人,他们患有潜在的免疫缺陷疾病并因医学原因而受到免疫抑制。其候选产品包括BIVIGAM,这一种用于治疗原发性体液免疫缺陷(PI)的静脉免疫球蛋白(IVIG)产品;ASCENIV是一种IVIG产品,用于治疗PI,而Nabi-HB用于治疗急性暴露于含有乙型肝炎表面抗原 (HBsAg) 的血液。其ADMA BioCenters子公司在美国经营源血浆采集设施。其血浆采集中心部门为制造其候选产品提供部分血浆。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Jerrold B. Grossman | 73 | 2007 | Co-Founder & Vice Chairman of the Board |
Bryant E. Fong | 48 | 2012 | Independent Director |
Lawrence P. Guiheen | 70 | 2012 | Independent Director |
Steven Arnote Elms | 58 | 2007 | Independent Chairman |
Jordan Scott Orange | - | 2014 | Member of Scientific Advisory Board |
Roy F. Chemaly | - | 2014 | Member of Scientific Advisory Board |
Jean-Laurent Casanova | - | - | Member of Scientific Advisory Board |
Young T. Kwon | 50 | 2021 | Independent Director |
Ann R. Falsey | - | - | Member of Scientific Advisory Board |
Michael D. Green | - | - | Member of Scientific Advisory Board |
Adam S. Grossman | 47 | 2007 | Co-Founder, President, CEO, Interim CFO & Director |
Alison Cecily Finger | 59 | 2023 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核